ヒト化マウスモデルの世界市場 2024-2028

概要

ヒト化マウスモデル市場は2023-2028年に1億860万米ドル、予測期間中のCAGRは10.22%で成長すると予測されています。

当レポートでは、ヒト化マウスモデル市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。個別化医療の採用拡大、ヒト化マウスモデルの革新的応用、遺伝子工学技術の進歩などが市場を牽引しています。

本調査では、今後数年間のヒト化マウスモデル市場の成長を促進する主な理由の一つとして、ベンダーの戦略的提携を挙げています。また、MABの生産量の増加や全動物イメージングの出現は、市場の大きな需要につながっています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• ヒト化マウスモデルの世界市場 2018-2022
• エンドユーザーセグメント分析 2018-2022
• 製品セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 製薬会社およびバイオテクノロジー会社：市場規模と予測 2023-2028
• CRO：市場規模と予測 2023-2028
• 学術調査機関：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• 遺伝的ヒト化マウスモデル：市場規模と予測 2023-2028
• 細胞ベースのヒト化マウスモデル：市場規模と予測 2023-2028
• 市場機会：製品別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Altogen labs
• Aragen Life Sciences Pvt. Ltd.
• Biocytogen
• BioSafety Research Center Inc.
• Champions Oncology Inc.
• Charles River Laboratories International Inc.
• Creative Biolabs
• Cyagen Biosciences
• Gempharmatech Co. Ltd.
• genOway
• HBM Holdings Ltd.
• Hera Biolabs Inc.
• ingenious targeting laboratory
• JSR Corp.
• PerkinElmer Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on CROs - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Product - Market share 2023-2028 (%)
• Exhibits49: Data Table on Product - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Product
• Exhibits51: Data Table on Comparison by Product
• Exhibits52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by Product ($ million)
• Exhibits61: Data Table on Market opportunity by Product ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Altogen labs - Overview
• Exhibits112: Altogen labs - Product / Service
• Exhibits113: Altogen labs - Key offerings
• Exhibits114: Aragen Life Sciences Pvt. Ltd. - Overview
• Exhibits115: Aragen Life Sciences Pvt. Ltd. - Product / Service
• Exhibits116: Aragen Life Sciences Pvt. Ltd. - Key news
• Exhibits117: Aragen Life Sciences Pvt. Ltd. - Key offerings
• Exhibits118: Biocytogen - Overview
• Exhibits119: Biocytogen - Product / Service
• Exhibits120: Biocytogen - Key offerings
• Exhibits121: BioSafety Research Center Inc. - Overview
• Exhibits122: BioSafety Research Center Inc. - Product / Service
• Exhibits123: BioSafety Research Center Inc. - Key offerings
• Exhibits124: Champions Oncology Inc. - Overview
• Exhibits125: Champions Oncology Inc. - Product / Service
• Exhibits126: Champions Oncology Inc. - Key news
• Exhibits127: Champions Oncology Inc. - Key offerings
• Exhibits128: Charles River Laboratories International Inc. - Overview
• Exhibits129: Charles River Laboratories International Inc. - Business segments
• Exhibits130: Charles River Laboratories International Inc. - Key news
• Exhibits131: Charles River Laboratories International Inc. - Key offerings
• Exhibits132: Charles River Laboratories International Inc. - Segment focus
• Exhibits133: Creative Biolabs - Overview
• Exhibits134: Creative Biolabs - Product / Service
• Exhibits135: Creative Biolabs - Key offerings
• Exhibits136: Cyagen Biosciences - Overview
• Exhibits137: Cyagen Biosciences - Product / Service
• Exhibits138: Cyagen Biosciences - Key offerings
• Exhibits139: Gempharmatech Co. Ltd. - Overview
• Exhibits140: Gempharmatech Co. Ltd. - Product / Service
• Exhibits141: Gempharmatech Co. Ltd. - Key offerings
• Exhibits142: genOway - Overview
• Exhibits143: genOway - Product / Service
• Exhibits144: genOway - Key offerings
• Exhibits145: HBM Holdings Ltd. - Overview
• Exhibits146: HBM Holdings Ltd. - Product / Service
• Exhibits147: HBM Holdings Ltd. - Key offerings
• Exhibits148: Hera Biolabs Inc. - Overview
• Exhibits149: Hera Biolabs Inc. - Product / Service
• Exhibits150: Hera Biolabs Inc. - Key offerings
• Exhibits151: ingenious targeting laboratory - Overview
• Exhibits152: ingenious targeting laboratory - Product / Service
• Exhibits153: ingenious targeting laboratory - Key offerings
• Exhibits154: JSR Corp. - Overview
• Exhibits155: JSR Corp. - Business segments
• Exhibits156: JSR Corp. - Key offerings
• Exhibits157: JSR Corp. - Segment focus
• Exhibits158: PerkinElmer Inc. - Overview
• Exhibits159: PerkinElmer Inc. - Business segments
• Exhibits160: PerkinElmer Inc. - Key news
• Exhibits161: PerkinElmer Inc. - Key offerings
• Exhibits162: PerkinElmer Inc. - Segment focus
• Exhibits163: Inclusions checklist
• Exhibits164: Exclusions checklist
• Exhibits165: Currency conversion rates for US$
• Exhibits166: Research methodology
• Exhibits167: Validation techniques employed for market sizing
• Exhibits168: Information sources
• Exhibits169: List of abbreviations

Abstract

The humanized mouse model market is forecasted to grow by USD 108.6 mn during 2023-2028, accelerating at a CAGR of 10.22% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

Technavio's humanized mouse model market is segmented as below:

By End-user

• Pharmaceutical and biotechnology companies
• CROs
• Academic and research institutions

By Product

• Genetically humanized mouse model
• Cell-based humanized mouse model

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strategic alliances of vendors as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of MABs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

• Humanized mouse model market sizing
• Humanized mouse model market forecast
• Humanized mouse model market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., genOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv, Inc., JANVIER LABS, JSR Corp., Oncodesign SA, Ozgene Pty Ltd., PerkinElmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global humanized mouse model market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global humanized mouse model market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• 6.4 CROs - Market size and forecast 2023-2028
• Exhibit 38: Chart on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on CROs - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on CROs - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on CROs - Year-over-year growth 2023-2028 (%)
• 6.5 Academic and research institutions - Market size and forecast 2023-2028
• Exhibit 42: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Genetically humanized mouse model - Market size and forecast 2023-2028
• Exhibit 52: Chart on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Genetically humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Genetically humanized mouse model - Year-over-year growth 2023-2028 (%)
• 7.4 Cell-based humanized mouse model - Market size and forecast 2023-2028
• Exhibit 56: Chart on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Cell-based humanized mouse model - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Cell-based humanized mouse model - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
• Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 France - Market size and forecast 2023-2028
• Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Altogen labs
• Exhibit 111: Altogen labs - Overview
• Exhibit 112: Altogen labs - Product / Service
• Exhibit 113: Altogen labs - Key offerings
• 12.4 Aragen Life Sciences Pvt. Ltd.
• Exhibit 114: Aragen Life Sciences Pvt. Ltd. - Overview
• Exhibit 115: Aragen Life Sciences Pvt. Ltd. - Product / Service
• Exhibit 116: Aragen Life Sciences Pvt. Ltd. - Key news
• Exhibit 117: Aragen Life Sciences Pvt. Ltd. - Key offerings
• 12.5 Biocytogen
• Exhibit 118: Biocytogen - Overview
• Exhibit 119: Biocytogen - Product / Service
• Exhibit 120: Biocytogen - Key offerings
• 12.6 BioSafety Research Center Inc.
• Exhibit 121: BioSafety Research Center Inc. - Overview
• Exhibit 122: BioSafety Research Center Inc. - Product / Service
• Exhibit 123: BioSafety Research Center Inc. - Key offerings
• 12.7 Champions Oncology Inc.
• Exhibit 124: Champions Oncology Inc. - Overview
• Exhibit 125: Champions Oncology Inc. - Product / Service
• Exhibit 126: Champions Oncology Inc. - Key news
• Exhibit 127: Champions Oncology Inc. - Key offerings
• 12.8 Charles River Laboratories International Inc.
• Exhibit 128: Charles River Laboratories International Inc. - Overview
• Exhibit 129: Charles River Laboratories International Inc. - Business segments
• Exhibit 130: Charles River Laboratories International Inc. - Key news
• Exhibit 131: Charles River Laboratories International Inc. - Key offerings
• Exhibit 132: Charles River Laboratories International Inc. - Segment focus
• 12.9 Creative Biolabs
• Exhibit 133: Creative Biolabs - Overview
• Exhibit 134: Creative Biolabs - Product / Service
• Exhibit 135: Creative Biolabs - Key offerings
• 12.10 Cyagen Biosciences
• Exhibit 136: Cyagen Biosciences - Overview
• Exhibit 137: Cyagen Biosciences - Product / Service
• Exhibit 138: Cyagen Biosciences - Key offerings
• 12.11 Gempharmatech Co. Ltd.
• Exhibit 139: Gempharmatech Co. Ltd. - Overview
• Exhibit 140: Gempharmatech Co. Ltd. - Product / Service
• Exhibit 141: Gempharmatech Co. Ltd. - Key offerings
• 12.12 genOway
• Exhibit 142: genOway - Overview
• Exhibit 143: genOway - Product / Service
• Exhibit 144: genOway - Key offerings
• 12.13 HBM Holdings Ltd.
• Exhibit 145: HBM Holdings Ltd. - Overview
• Exhibit 146: HBM Holdings Ltd. - Product / Service
• Exhibit 147: HBM Holdings Ltd. - Key offerings
• 12.14 Hera Biolabs Inc.
• Exhibit 148: Hera Biolabs Inc. - Overview
• Exhibit 149: Hera Biolabs Inc. - Product / Service
• Exhibit 150: Hera Biolabs Inc. - Key offerings
• 12.15 ingenious targeting laboratory
• Exhibit 151: ingenious targeting laboratory - Overview
• Exhibit 152: ingenious targeting laboratory - Product / Service
• Exhibit 153: ingenious targeting laboratory - Key offerings
• 12.16 JSR Corp.
• Exhibit 154: JSR Corp. - Overview
• Exhibit 155: JSR Corp. - Business segments
• Exhibit 156: JSR Corp. - Key offerings
• Exhibit 157: JSR Corp. - Segment focus
• 12.17 PerkinElmer Inc.
• Exhibit 158: PerkinElmer Inc. - Overview
• Exhibit 159: PerkinElmer Inc. - Business segments
• Exhibit 160: PerkinElmer Inc. - Key news
• Exhibit 161: PerkinElmer Inc. - Key offerings
• Exhibit 162: PerkinElmer Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 163: Inclusions checklist
• Exhibit 164: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 165: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 166: Research methodology
• Exhibit 167: Validation techniques employed for market sizing
• Exhibit 168: Information sources
• 13.5 List of abbreviations
• Exhibit 169: List of abbreviations